Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

[Application of hydroxychloroquine in children with systemic lupus erythematosus].

Yang SJ, Song HM.

Zhonghua Er Ke Za Zhi. 2019 Jun 2;57(6):490-493. doi: 10.3760/cma.j.issn.0578-1310.2019.06.019. Chinese.

PMID:
31216811
2.

Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.

Ugarte A, Porta S, Ríos R, Martinez-Zapico A, Ortego-Centeno N, Agesta N, Ruiz-Irastorza G.

Lupus. 2018 Sep;27(10):1718-1722. doi: 10.1177/0961203318768877. Epub 2018 Apr 10.

PMID:
29635998
3.

Risk of high-grade cervical dysplasia and cervical cancer in women with systemic lupus erythematosus receiving immunosuppressive drugs.

Feldman CH, Liu J, Feldman S, Solomon DH, Kim SC.

Lupus. 2017 Jun;26(7):682-689. doi: 10.1177/0961203316672928. Epub 2016 Oct 31.

4.

Longitudinal melanonychia and subungual hemorrhage in a patient with systemic lupus erythematosus treated with hydroxychloroquine.

Zhang S, Liu X, Cai L, Zhang J, Zhou C.

Lupus. 2019 Jan;28(1):129-132. doi: 10.1177/0961203318812685. Epub 2018 Nov 14.

PMID:
30428763
5.

Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.

Fasano S, Margiotta DP, Navarini L, Pierro L, Pantano I, Riccardi A, Afeltra A, Valentini G.

Lupus. 2017 Dec;26(14):1463-1472. doi: 10.1177/0961203317722847. Epub 2017 Aug 8. Review.

PMID:
28786768
6.

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.

Canadian Hydroxychloroquine Study Group.

N Engl J Med. 1991 Jan 17;324(3):150-4.

7.

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients.

Silva JC, Mariz HA, Rocha LF Jr, Oliveira PS, Dantas AT, Duarte AL, Pitta Ida R, Galdino SL, Pitta MG.

Clinics (Sao Paulo). 2013 Jun;68(6):766-71. doi: 10.6061/clinics/2013(06)07.

8.

Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.

Antón Vázquez V, Pascual L, Corominas H, Giménez Torrecilla I.

Reumatol Clin. 2017 Sep - Oct;13(5):294-296. doi: 10.1016/j.reuma.2016.04.008. Epub 2016 Jun 2. English, Spanish.

9.

Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.

Ototake Y, Yamaguchi Y, Kanaoka M, Akita A, Ikeda N, Aihara M.

J Dermatol. 2019 Apr;46(4):285-289. doi: 10.1111/1346-8138.14802. Epub 2019 Feb 5.

PMID:
30719729
10.

Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients.

Petri M.

Curr Rheumatol Rep. 2011 Feb;13(1):77-80. doi: 10.1007/s11926-010-0141-y. Review.

PMID:
20978875
11.

Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus.

Gómez-Guzmán M, Jiménez R, Romero M, Sánchez M, Zarzuelo MJ, Gómez-Morales M, O'Valle F, López-Farré AJ, Algieri F, Gálvez J, Pérez-Vizcaino F, Sabio JM, Duarte J.

Hypertension. 2014 Aug;64(2):330-7. doi: 10.1161/HYPERTENSIONAHA.114.03587. Epub 2014 May 19.

PMID:
24842914
12.

Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.

Momose Y, Arai S, Eto H, Kishimoto M, Okada M.

J Dermatol. 2013 Feb;40(2):94-7. doi: 10.1111/1346-8138.12005. Epub 2012 Dec 6.

PMID:
23216212
13.

Hydroxychloroquine in systemic lupus erythematosus (SLE).

Ponticelli C, Moroni G.

Expert Opin Drug Saf. 2017 Mar;16(3):411-419. doi: 10.1080/14740338.2017.1269168. Epub 2016 Dec 14. Review.

PMID:
27927040
14.

[THE VALUE OF HYDROXYCHLOROQUINE (PLAQUENIL) THERAPY IN CHRONIC DISCOID LUPUS ERYTHEMATOSUS].

KRAAK JH, VAN KETEL W, PRAKKEN JR, VAN ZWET W.

Ned Tijdschr Geneeskd. 1965 Mar 6;109:461-9. Dutch. No abstract available.

PMID:
14339782
15.

CHILBLAIN LUPUS ERYTHEMATOSUS.

BETTLEY FR.

Proc R Soc Med. 1964 Jun;57:515-6. No abstract available.

16.

Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.

Parke A, West B.

J Rheumatol. 1996 Oct;23(10):1715-8.

PMID:
8895146
17.

Restrictive Cardiomyopathy Associated With Long-Term Use of Hydroxychloroquine for Systemic Lupus Erythematosus.

Sabato LA, Mendes LA, Cox ZL.

J Pharm Pract. 2017 Oct;30(5):571-575. doi: 10.1177/0897190016655726. Epub 2016 Jun 26. Review.

PMID:
27353145
18.

Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.

Cohen EM, D'Silva K, Kreps D, Son MB, Costenbader KH.

Lupus. 2018 Jun;27(7):1065-1071. doi: 10.1177/0961203318759428. Epub 2018 Feb 16.

19.

Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.

Durcan L, Winegar DA, Connelly MA, Otvos JD, Magder LS, Petri M.

J Rheumatol. 2016 Apr;43(4):745-50. doi: 10.3899/jrheum.150437. Epub 2016 Feb 1.

20.

THE VALUE OF HYDROXYCHLOROQUINE (PLAQUENIL) FOR THE TREATMENT OF CHRONIC DISCOID LUPUS ERYTHEMATOSUS; A DOUBLE BLIND TRIAL.

KRAAK JH, VAN KETEL W, PRAKKEN JR, VAN ZWET W.

Dermatologica. 1965;130:293-305. No abstract available.

PMID:
14333636

Supplemental Content

Support Center